Capital World Investors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-497,851
| Closed | -$280M | – | 665 |
|
|
2026
Q1 | $280M | Buy |
+497,851
| New | +$319M | 0.04% | 266 |
|
|
2024
Q1 | – | Sell |
-1,022,678
| Closed | -$568M | – | 524 |
|
|
2023
Q4 | $568M | Buy |
1,022,678
+11,351
| +1% | +$5.33M | 0.1% | 179 |
|
|
2023
Q3 | $442M | Buy |
1,011,327
+4,254
| +0.4% | +$2.12M | 0.09% | 197 |
|
|
2023
Q2 | $506M | Buy |
1,007,073
+8,310
| +0.8% | +$3.98M | 0.1% | 191 |
|
|
2023
Q1 | $499M | Buy |
998,763
+3,906
| +0.4% | +$1.87M | 0.1% | 190 |
|
|
2022
Q4 | $406M | Buy |
994,857
+1,948
| +0.2% | +$756K | 0.09% | 200 |
|
|
2022
Q3 | $324M | Sell |
992,909
-3,076
| -0.3% | -$1.13M | 0.07% | 218 |
|
|
2022
Q2 | $349M | Sell |
995,985
-3,117
| -0.3% | -$1.27M | 0.07% | 220 |
|
|
2022
Q1 | $547M | Buy |
999,102
+4,587
| +0.5% | +$2.41M | 0.09% | 191 |
|
|
2021
Q4 | $655M | Buy |
994,515
+3,673
| +0.4% | +$2.31M | 0.1% | 186 |
|
|
2021
Q3 | $616M | Buy |
990,842
+9,582
| +1% | +$6.44M | 0.11% | 192 |
|
|
2021
Q2 | $620M | Buy |
981,260
+7,260
| +0.7% | +$4.01M | 0.11% | 192 |
|
|
2021
Q1 | $477M | Buy |
974,000
+8,324
| +0.9% | +$4.17M | 0.09% | 199 |
|
|
2020
Q4 | $483M | Buy |
965,676
+8,624
| +0.9% | +$3.86M | 0.09% | 199 |
|
|
2020
Q3 | $376M | Sell |
957,052
-134,316
| -12% | -$49.7M | 0.08% | 214 |
|
|
2020
Q2 | $360M | Sell |
1,091,368
-14,937
| -1% | -$4.32M | 0.09% | 196 |
|
|
2020
Q1 | $268M | Buy |
1,106,305
+6,709
| +0.6% | +$1.75M | 0.08% | 204 |
|
|
2019
Q4 | $287M | Buy |
1,099,596
+9,669
| +0.9% | +$2.55M | 0.06% | 227 |
|
|
2019
Q3 | $296M | Buy |
1,089,927
+3,468
| +0.3% | +$965K | 0.07% | 208 |
|
|
2019
Q2 | $299M | Buy |
1,086,459
+4,086
| +0.4% | +$1.01M | 0.07% | 213 |
|
|
2019
Q1 | $242M | Buy |
1,082,373
+7,838
| +0.7% | +$1.62M | 0.06% | 226 |
|
|
2018
Q4 | $200M | Buy |
1,074,535
+2,060
| +0.2% | +$422K | 0.05% | 231 |
|
|
2018
Q3 | $268M | Buy |
1,072,475
+3,693
| +0.3% | +$896K | 0.07% | 220 |
|
|
2018
Q2 | $233M | Buy |
1,068,782
+5,431
| +0.5% | +$1.12M | 0.05% | 230 |
|
|
2018
Q1 | $204M | Buy |
1,063,351
+3,642
| +0.3% | +$672K | 0.05% | 235 |
|
|
2017
Q4 | $166M | Buy |
1,059,709
+5,585
| +0.5% | +$879K | 0.04% | 253 |
|
|
2017
Q3 | $164M | Buy |
1,054,124
+3,203
| +0.3% | +$506K | 0.04% | 251 |
|
|
2017
Q2 | $170M | Buy |
1,050,921
+2,491
| +0.2% | +$405K | 0.04% | 240 |
|
|
2017
Q1 | $162M | Buy |
+1,048,430
| New | +$145M | 0.04% | 241 |
|
Other funds holding IDXX
Capital World Investors's IDXX Position: Q2 2026 in Review
Capital World Investors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 497,851 shares — an estimated $280M sold.
Capital World Investors first reported a position in IDXX in Q1 2017 and held it in 29 quarters. The position peaked at $655M in Q4 2021. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Capital World Investors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- Capital World Investors sold 497,851 Idexx Laboratories shares in Q2 2026, an estimated $280M.
- Capital World Investors first reported a position in Idexx Laboratories in Q1 2017 and held it in 29 quarters.
- Capital World Investors's Idexx Laboratories position peaked at $655M in Q4 2021.
- 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.